Related Experiment Video
Updated: Mar 8, 2026

Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients
Published on: March 1, 2024
Lung Infections in Systemic Rheumatic Disease: Focus on Opportunistic Infections
Manuela Di Franco1, Bruno Lucchino2, Martina Spaziante3
1Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Rome 00161, Italy. manuela.difranco@uniroma1.it.
Abstract:
Systemic rheumatic diseases have significant morbidity and mortality, due in large part to concurrent infections. The lung has been reported among the most frequent sites of infection in patients with rheumatic disease, who are susceptible to developing pneumonia sustained both by common pathogens and by opportunistic microorganisms. Patients with rheumatic disease show a peculiar vulnerability to infectious complications. This is due in part to intrinsic disease-related immune dysregulation and in part to the immunosuppressive treatments. Several therapeutic agents have been associated to a wide spectrum of infections, complicating the management of rheumatic diseases. This review discusses the most frequent pulmonary infections encountered in rheumatic diseases, focusing on opportunistic agents, consequent diagnostic challenges and appropriate therapeutic strategies.
Insights
Patients with rheumatic diseases face high risks of lung infections from common and opportunistic pathogens. This review covers frequent pulmonary infections, diagnostic challenges, and treatment strategies for these vulnerable patients.
Area of Science:
- Rheumatology
- Infectious Diseases
- Pulmonology
Background:
- Systemic rheumatic diseases are associated with significant morbidity and mortality, often due to infections.
- The lungs are a common site for infections in patients with rheumatic diseases.
- Patients with rheumatic diseases are susceptible to infections due to immune dysregulation and immunosuppressive treatments.
Purpose of the Study:
- To review the most frequent pulmonary infections in patients with rheumatic diseases.
- To focus on opportunistic agents causing lung infections in this population.
- To discuss diagnostic challenges and therapeutic strategies for managing these infections.
Main Methods:
- Literature review of studies on pulmonary infections in rheumatic diseases.
- Analysis of common and opportunistic pathogens involved.
- Evaluation of diagnostic approaches and treatment options.
Main Results:
- Pneumonia is a frequent complication in rheumatic disease patients.
- Both common and opportunistic microorganisms can cause lung infections.
- Immunosuppressive therapies increase susceptibility to a wide spectrum of infections.
Conclusions:
- Pulmonary infections pose a significant threat to patients with rheumatic diseases.
- Early diagnosis and appropriate management are crucial.
- Understanding opportunistic agents and treatment strategies is vital for improving patient outcomes.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

